is a pharmacotherapy for alcoholism that affects the NMDA receptor and the metabotropic glutamate receptors.

Question

Quizplus · Accepted Answer

Acamprosate is a pharmacotherapy for alcoholism that affects both the NMDA receptor and the metabotropic glutamate receptors. It helps to reduce alcohol cravings and prevent relapse by balancing the chemicals in the brain that have been disrupted by prolonged alcohol use. Naltrexone, on the other hand, works by blocking the effects of opioids and reducing the reward associated with alcohol consumption. Buspirone and sertraline are not typically used in the treatment of alcoholism.

Is a Pharmacotherapy for Alcoholism That Affects the NMDA Receptor